The diagnostic significance of lactate dehydrogenase isoenzymes in urinary cytology. by Nishikawa, A. et al.
Br. J. Cancer (1991), 63, 819-821
The diagnostic significance of lactate dehydrogenase isoenzymes in
urinary cytology
A. Nishikawal,*, T. Tanaka', T. Takeuchi2, S. Fujihiro2 & H. Mon'
Department of 'Pathology and 2Urology, Gifu University School ofMedicine, 40 Tsukasa-machi, Gifu 500, Japan.
Summary Lactate dehydrogenase (LDH) isoenzyme distribution was examined in 106 urine samples being
tested cytologically for evidence of bladder cancer; the samples were selected to have <20 leucocytes and
erythrocytes per high power field and the LDH pattern determined by electrophoresis. The Papanicolaou
stained-smears showed 68 negative, 17 suspicious and 21 positive. The LDH M-fraction of the urinary
supernatant in cytologically positive cases was significantly greater than in negative cases, although the latter
included a few false negative samples. Some of the false negatives gave positive results for the LDH
M-fraction; these results suggest that the determination of LDH isoenzymes in the urine is useful in diagnosing
urinary tract cancers, including early stage, and for follow-up of patients with bladder cancers after surgical
resection.
Because of such advantages as the ease of sample collection,
the ability to test frequently and the absence of risk to
patients, urine cytology has been regarded as one of the most
useful diagnostic procedures for the screening ofurinary tract
neoplasms as well as for their post-operative follow-up (Fujii
et al., 1982). The diagnostic accuracy of urine cytology,
however, is assumed to be not so great as that for other
organs, because ofcellular degeneration caused by hypertonic
urine, relatively low exfoliation and the cytomorphological
similarities of neoplastic cells, especially well differentiated
papillary tumours, to normal urothelial cells (Fujii et al.,
1982).
The presence of lactate dehydrogenase (LDH) activity in
urine was initially reported by Rosalki and Wilkinson (1959).
Although Wacker and Dorfman (1962) noted elevated levels
of LDH activity in the urine of patients with carcinoma of
the urinary tract, the elevation of total urinary LDH activity
is not now assumed to be cancer specific (Posey & Morgan,
1977). Increased urinary LDH may reflect contamination of
urine with cells such as polymorphonuclear leucocytes, or
proteinuria rather than the presence ofneoplasia (Mirabile et
al., 1966; Malik et al., 1983). It has also been suggested that
urinary LDH isoenzyme patterns vary according to the site
of inflammation in the urinary tract (Devaskar & Monto-
gomery, 1978). However, unless urine is heavily contamin-
ated with inflammatory cells, the M-fraction ofurinary LDH
may increase with the rising stage and the grade of the
bladder tumour (Mortomiya et al., 1975, 1979). Therefore, it
has been emphasised that the combination of urinary cyto-
logy and the determination of urinary LDH isoenzymes may
be of value in the diagnosis of bladder tumours (Motomiya
et al., 1975, 1979). In the present study, urinary LDH iso-
enzymes were evaluated in urinary specimens examined by
routine cytology.
Materials and methods
Urinary specimens collected from routine cytology were cen-
trifuged at 1,500 r.p.m. for 10 min. The urinary sediments
were smeared on thinly albuminised clean glass slides, fixed
in 95% ethanol and stained according to the Papanicolaou
*Present address: Division of Chemical Carcinogenesis, American
Health Foundation, 1 Dana Road, Valhalla, NY 10595, USA.
Correspondence: A. Nishikawa, Division of Chemical Carcino-
genesis, American Health Foundation, I Dana Road, Valhalla, NY
10595, USA.
Received 6 September 1989; and in revised fonn 2 August 1990.
method. Simultaneously, air-dried smears were also prepared
for Giemsa stain to determine the number of contaminating
leucocytes and erythrocytes per high powered field (x 400).
Cytological findings were interpreted as negative, suspicious
or positive for malignant cells in the Papanicolaou-smears.
Thus, a total of 106 specimens which contained less tjhan 20
leucocytes and less than 20 erythrocytes per high power field
and were cytologically diagnosed as negative in 68 cases
(Group I), suspicious in 17 cases (Group II) and positive in
21 cases (Group III) were used for the determination of LDH
isoenzyme distribution.
LDH isoenzyme determination in urinary supernatant, for
5 ml aliquots of the supernatant were concentrated approxi-
mately 50 times by Minicon B15 (Amicon Corp, Danvers,
USA), and then subjected to electrophoresis. Electrophoresis
was carried out using a polyacrylamide gel plate (Eiken-kizai
Co, Tokyo, Japan) at 2 mA cm-' for 2 h in a borate buffer
system (pH 8.2). The gel plate was then incubated for 60min
at 37°C in pH 7.4 Tris HCI buffer solution, containing 5 ml
0.4gdl-' KCN, 4ml 2M sodium lactate, 5ml 20mgdlh
phenazine methosulfate, 40 mg P-NAD, and 30 mg NBT in a
total volume of 70 ml. The isoenzyme bands were quantified
with a Fujiox model FDA-IV densitometer (Fuji-riken Co,
Tokyo, Japan), and each isoenzyme peak was quantified and
normalised to a percentage of the total. Reproducibility of
the LDH isoenzyme assay under the above conditions was
confirmed in our laboratory (Fujii et al., 1982; Fujii et al.,
1984; Tanaka et al., 1984). The M/H ratio was calculated as
follows:
M/H ratio =LDH2 x I + LDH3 x 2 + LDH4 x 3 + LDH5 x 4
LDHI x4+LDH2x 3+LDH3 x2+LDH4x 1
Statistical analysis was subjected to be the Student's t-test.
Results
LDH isoenzyme distribution and the M/H ratio of the 106
urinary supernatants are shown in Figure 1. In Group I, the
main LDH isoenzyme was LDH-1 and the amounts of the
remaining isoenzymes gradually decreased towards LDH-5.
The LDH isoenzyme pattern in Group II was almost the
same as that in Group I, though mild deviation favouring the
M-fraction was noted in Group II. The amount of LDH-1 in
Group I was significantly higher than that of Group II
(P<0.05), and the amount of LDH-5 in Group I was signi-
ficantly lower than that in Group II (P<0.05). Thus, the
M/H ratio in Group II was higher than that of Group I,
although the statistical significance was not observed. Com-
pared to the other two groups, a remarkable deviation
towards the M-fraction was noted in Group III. In Group
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Figure 1 Diagram showing urinary LDH isoenzyme distribution
and cytological diagnosis. The cytological diagnosis is interpreted
as negative (Group I), suspicious (Group II) and positive (Group
III).
LDH-2 x I + LDH-3 x 2+ LDH-4 x 3 + LDH-5 x 4
M/H= LDH-1 x4+LDH-2x 3+LDH-3 x2+LDH-4x 1
Values indicate mean + standard deviation. *Significantly differ-
ent from Group I (P<0.025). **Significantly different from Group
I (P<0.001) and Group II (P<0.05). ***Significantly different
from Group I (P<0.001).
III, the predominant LDH isoenzyme was LDH-2, though
there was nearly as much LDH-1 and LDH-3. The amount
of LDH-1 in Group III was significantly less .than the
amounts of LDH-l in either Group I or Group II (P<0.001
or 0.025). In contrast, the amount of LDH-3 in Group III
was significantly higher than that in Groups I or II
(P<0.001 or 0.005). The amount of LDH-4 in Group III
was also significantly higher than that in Groups I or II
(P<0.001 or 0.01). The amount of LDH-5 in Group III was
significantly higher than that in Group I (P<0.001). Thus,
the M/H ratio in Group III was significantly higher than that
in Group I (P<0.001).
All 21 cases in Group III were histologically diagnosed as
having transitional cell carcinoma of the bladder. Therefore,
cytologically false positive cases were not present. Mean-
while, of the 68 cases of Group I, five cases proved to have
bladder cancers which were diagnosed histologically. They
were regarded as so-called 'cytologically false negative cases'.
The LDH isoenzyme distribution and M/H ratio of such
false negative cases are shown in Table I (Cases 1-5).
Although four out of the five cases showed as low as M/H
ratio as the average of that of Group I, one case (Case 5)
had a higher M/H ratio than the average value in Group III.
A few atypical cells suggestive of papilloma or well differ-
entiated papillary carcinoma were noted upon re-examination
of the urinary smear of Case 5. However, neoplastic cells
were not detected in the urinary smears of the other four
cases even upon re-examination. Of the 17 cases in Group II,
five cases also proved to have bladder cancers upon histo-
logical examination. The LDH isoenzyme distribution and
the M/H ratio of the five cases are also shown in Table I
(Cases 6-10). Two (Cases 7 and 9) out of the five cases
showed a higher M/H ratio than the average value in Group
III. The urinary smears of the five cases were reviewed in
detail and a few atypical cells indicative of grade 2 transi-
tional cell carcinoma were noticed in the smear of Case 7,
but not in Case 9.
Discussion
The results in the present study showed that the LDH M-
fraction of the urinary supernatant in cytologically positive
cases is significantly larger in amount than that in cyto-
logically negative cases, although a few cytologically false
negative cases are present in the latter. Also, the LDH M-
fraction in cytologically suspicious cases was larger in
amount than that in cytologically negative cases and smaller
in amount than that in cytologically positive cases.
LDH, a key enzyme in glycolysis, is electrophoretically
separated into five isoenzymes named LDHI-5, based on the
fact that LDH is a tetramer composed of two kinds of
subunits called the H- and the M-fraction. It has been
reported that the LDH isoenzyme M-fraction in the tissues of
malignant tumours becomes elevated compared to those
levels expected in normal tissues (Macbeth & Bekesi, 1962;
Goldman et al., 1964). The hypothesis which has been
advanced to account for this skewing of the M/H ratio is
that malignant tumours derive most of their energy from
anaerobic glycolysis. Though this reaction is catalysed by
LDH, it is the M-fraction which is favoured (Dawson et al.,
1964). It is also suggested that a modulation vs primary gene
expression of LDH in isoenzymes may be occurring (Ibsen &
Fishman, 1979). A basic LDH isoenzyme, LDHk has been
implicated as an oncogene product of the Kirsten murine
sarcoma virus and has been found at elevated levels in some
cancers (Anderson & Kovacik, 1981). However, it has been
also suggested by some investigators that LDHk may be
identical to LDH-5 (Morin & Hance, 1983; Evans et al.,
1985). Thus, in many human organs like the prostate, kidney,
colon, mammary gland, lung and brain, the LDH isoenzyme
M/H ratio increases in malignant tumours arising in these
sites (Elhilani et al., 1967; Matsuda et al., 1980; Carda-Abella
et al., 1982; Balinsky et al., 1983, 1984; Tanaka et al., 1984;
Fujii et al., 1984). Furthermore, Langvad (1968) reported
that the M/H ratio increase of LDH precedes the histological
changes which indicated malignancy in the bronchial mucous
epithelium. The M/H increase of LDH isoenzymes has also
been confirmed in extracts of human neoplastic bladder tis-
sues (Bredin et al., 1975). The deviation may increase in
degree according to the degree of histological grade or stage
(Bredin et al., 1975). Fujii et al. (1982) have reported that
such precancerous bladder lesions like hyperplasia already
tend to exhibit a deviation towards the LDH M-fraction in
Table I Urinary LDH isoenzyme distribution in the falsely negative and suspicious
cases
Case % LDH isoenzyme distribution
no. Cytology LDH-1 LDH-2 LDH-3 LDH-4 LDH-5 M/H
1 Negative 38.4 44.1 17.1 0.5 ND* 0.25
2 Negative 45.7 34.1 11.9 6.1 2.1 0.27
3 Negative 75.0 4.0 7.3 6.8 12.9 0.22
4 Negative 76.9 23.1 ND ND ND 0.06
5 Negative 9.0 20.5 26.4 29.7 14.4 1.22
6 Suspicious 44.4 44.4 11.2 ND ND 0.20
7 Suspicious 14.1 22.1 27.1 24.4 11.6 0.97
8 Suspicious 48.6 51.4 ND ND ND 0.15
9 Suspicious 23.4 18.3 18.8 20.6 19.0 0.94
10 Suspicious 41.7 45.8 12.5 ND ND 0.22
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rat urinary bladder carcinogenesis.
Meanwhile, Gelderman et al. (1965) reported that devia-
tion towards the LDH M-fraction in the urine is due to the
presence of increased leucocytes rather than the presence of
tumour cells derived from bladder cancers. It has also been
described that the determination of urinary LDH isoenzymes
may be more useful in diagnosing the location of urinary
tract infection rather than the presence of bladder neoplasias
because LDH-5 is usually elevated in upper urinary tract
infections (Fries et al., 1977; Devaskar et al., 1978; Lorentz et
al., 1979). Experimentally, Cunningham et al. (1977) have
confirmed the increased level of urinary LDH-5 in the rat
model of pyelonephritis. However, Motomiya et al. (1975,
1979) reported that the deviation of urinary LDH isoenzymes
towards the M-fraction becomes marked as the grade or
stage of bladder cancer increases unless there is noticeable
contamination of the urine with leucocytes. The results in the
present study support their results. Exfoliated cells from well
differentiated or early cancer of bladder are usually few and
may be difficult to distinguish from benign cells with cellular
atypia. Fujii et al. (1982) described that 90% of high grade
or invasive cancers exfoliated into the urine, whereas only
35% oflow grade or non-invasive cancers shed into the urine
in rat bladder carcinogenesis studies using N-butyl-N-(4-
hydroxybutyl)nitrosamine. In the present study, one false
negative case and two suspicious cases which proved to have
bladder cancers in urinary cytology showed a remarkable
increase in the LDH isoenzyme M/H ratio. These results
indicated that quantitative analysis of urinary LDH iso-
enzymes is useful for diagnosing urinary malignancy. This
examination is also a useful follow-up for post-operative
bladder cancer patients, after inflammation has subsided.
We are grateful to Dr. E. Zang for drawing the diagram and to
Dr Y. Xu and Ms Y. Lin for preparing the manuscript.
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